Provider review, September 2026
GoodGirlRx publishes a four-rung plan ladder for every product and its discount arithmetic checks out on all of them. It also carries a February 2026 federal warning letter naming its own website, and three of its product pages label their own price as a compounded tirzepatide price when they do not sell tirzepatide.
GoodGirlRx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
The NAD+ page, the glutathione page and the sermorelin-tablet page each print the sentence "Compounded tirzepatide from …" twice, and the figure it quotes is that page's own price.
So the number is real and the drug name attached to it is not. A reader shopping for NAD+ sees a tirzepatide claim built out of the NAD+ ladder; a reader shopping for tirzepatide who lands there sees a figure far below what tirzepatide actually costs on this site.
Nothing here is filed from that sentence. Every figure recorded for this seller was taken from the page's own plan ladder instead.
Each product publishes four rungs — one month, three, six and twelve — rather than a single floor with everything else hidden behind an intake.
The savings percentages printed against those rungs reconcile against the rungs themselves on all four ladders, which is not something every seller can say.
Sermorelin is priced twice, once as an injection and once as an oral tablet, so a reader choosing between the two forms has a figure for each.
The hero on each page quotes a from figure with an asterisk. Those are twelve-month prepay averages, not the price of a first month.
Only the one-month rung is filed here, because that is what a reader actually pays before committing to a year.
The gap matters most on tirzepatide, where the headline and the first month are far apart. Read the ladder, not the hero.
Its own words: "GoodGirlRx is a managed services organization that connects patients with independent, state-licensed pharmacies and licensed healthcare providers. GoodGirlRx is not a pharmacy, prescriber, or manufacturer." It also states that "Compounded medications are not FDA-approved."
That is a clear account of its role, and it is quoted rather than endorsed. But it names none of those independent pharmacies.
It makes no state-coverage claim either, so there is no way to check before intake whether it can serve a given reader.
GoodGirlRx received an FDA warning letter issued February 2026. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityYes. The letter's opening line names this site's own web address as the content reviewed, and the recipient block carries the company's registered name, its Nashville street address and a support email at this domain.
Because the page prints its own price under a tirzepatide label, twice. The number belongs to NAD+. The same fault appears on the glutathione page and the sermorelin-tablet page.
No. The headline figures are twelve-month prepay averages. The one-month rung on the ladder is what a first month costs, and it is higher on every product.
It does not say. It states that it is not a pharmacy and connects patients to independent state-licensed ones, but it names none of them.
GoodGirlRx is not a paid partner; this link may earn a commission if that changes. Full disclosure.